Eventide Asset Management - ZENTALIS PHARMACEUTICALS INC ownership

ZENTALIS PHARMACEUTICALS INC's ticker is ZNTL and the CUSIP is 98943L107. A total of 95 filers reported holding ZENTALIS PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Eventide Asset Management ownership history of ZENTALIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$156,749,622
-19.2%
7,814,039
+13.6%
2.82%
-14.1%
Q2 2023$194,022,823
+249.6%
6,877,803
+113.1%
3.28%
+222.1%
Q1 2023$55,504,400
+27.8%
3,227,000
+49.6%
1.02%
+18.9%
Q4 2022$43,432,212
+7.7%
2,156,515
+15.9%
0.86%
+7.9%
Q3 2022$40,309,000
+42.9%
1,861,000
+85.4%
0.79%
+31.5%
Q2 2022$28,212,000
-19.7%
1,004,000
+31.9%
0.60%
+9.6%
Q1 2022$35,113,000
-21.0%
761,000
+43.9%
0.55%
-3.2%
Q4 2021$44,468,000
+26.1%
529,0000.0%0.57%
+22.2%
Q3 2021$35,253,000
+57.6%
529,000
+25.8%
0.46%
+55.0%
Q2 2021$22,365,000
-38.0%
420,400
-49.5%
0.30%
-43.9%
Q1 2021$36,100,000
-16.5%
832,0000.0%0.54%
-19.3%
Q4 2020$43,214,000
+49.9%
832,000
-8.7%
0.66%
+17.6%
Q3 2020$28,822,000
-32.2%
911,416
-0.4%
0.56%
-39.0%
Q2 2020$42,496,000914,7050.92%
Other shareholders
ZENTALIS PHARMACEUTICALS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Decheng Capital Management III (Cayman), LLC 2,099,583$42,117,63514.06%
Mayo Clinic 187,143$3,754,0897.23%
Matrix Capital Management Company, LP 13,959,973$280,037,0583.36%
5AM Venture Management, LLC 490,000$9,829,4002.83%
Eventide Asset Management 7,814,039$156,749,6222.82%
TYBOURNE CAPITAL MANAGEMENT (HK) LTD 961,486$19,287,4102.70%
Avidity Partners Management LP 2,100,000$42,126,0001.70%
First Light Asset Management, LLC 848,477$17,020,4491.62%
Sofinnova Investments, Inc. 1,211,641$24,305,5181.53%
SECTORAL ASSET MANAGEMENT INC 386,525$7,753,6921.51%
View complete list of ZENTALIS PHARMACEUTICALS INC shareholders